Professor of Medicine, Johns Hopkins University School of Medicine
Pulmonology
Dr. David R. Moller, MD
|
|
Give Review
David Moller is an expert in the field of Pulmonology. He attended Tufts University School of Medicine. Tufts University School of Medicine is ranked 49/52 in Research/PrimaryCare. He has 1 awards "CMS Meaningful Use Stage 1 Certification". David Moller is a published physician. He has 58 papers published. The most current publication "T-cell receptor genes in sarcoidosis."
Publications
- Rationale and Design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis Study (GRADS): Sarcoidosis Protocol.
- Etiologies of Sarcoidosis.
- Negative clinical trials in Sarcoidosis: failed therapies or flawed study design?
- "Sarcoidosis: recent advances".
- Etiologic role of infectious agents.
- Linkage of Type I Interferon Activity and TNF-Alpha Levels in Serum with Sarcoidosis Manifestations and Ancestry.
- Serum amyloid A regulates granulomatous inflammation in Sarcoidosis through Toll-like receptor-2.
- Significant CD4, CD8, and CD19 lymphopenia in peripheral blood of sarcoidosis patients correlates with severe Disease manifestations.
- Treatment of sarcoidosis-associated Pulmonary hypertension. A two-center experience.
- T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic Sarcoidosis.
- Etiology of Sarcoidosis.
- Differential CMV-specific CD8+ effector T cell responses in the Lung allograft predominate over the blood during human primary infection.
- Potential etiologic agents in Sarcoidosis.
- Expression profiling in granulomatous lung Disease.
- Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic Sarcoidosis.
- Pulmonary fibrosis of sarcoidosis. New approaches, old ideas.
- Genetic basis of remitting Sarcoidosis: triumph of the trimolecular complex?
- What causes Sarcoidosis?
- Thalidomide for Chronic sarcoidosis.
- What is the latest thinking about the environmental causes of Sarcoidosis?
- Variation in the lymphotoxin-alpha/tumor necrosis factor locus modifies risk of erythema nodosum in Sarcoidosis.
- Sarcoidosis--scientific progress and clinical challenges.
- A case control etiologic study of Sarcoidosis: environmental and occupational risk factors.
- Two year prognosis of Sarcoidosis: the ACCESS experience.
- Job and industry classifications associated with Sarcoidosis in A Case-Control Etiologic Study of Sarcoidosis (ACCESS).
- Comparison of Sarcoidosis phenotypes among affected African-American siblings.
- Pulmonary and psychosocial findings at enrollment in the ACCESS study.
- The spectrum of biopsy sites for the diagnosis of Sarcoidosis.
- A Sarcoidosis genetic linkage consortium: the Sarcoidosis genetic analysis (SAGA) study.
- Use of fluticasone in acute symptomatic Pulmonary sarcoidosis.
- Inhibition of IL-12 production by thalidomide.
- Inhibition of human interleukin-12 production by pentoxifylline.
- Limited heterogeneity of biased T-cell receptor V beta gene usage in lung but not blood T cells in active Pulmonary sarcoidosis.
- Enhanced expression of IL-12 associated with Th1 cytokine profiles in active Pulmonary sarcoidosis.
- T cell receptor variable beta-gene expression in the normal lung and in active Pulmonary sarcoidosis.
- Selective activation and accumulation of oligoclonal V beta-specific T cells in active Pulmonary sarcoidosis.
- Selection of oligoclonal V beta-specific T cells in the intradermal response to Kveim-Siltzbach reagent in individuals with Sarcoidosis.
- Detection of IgE-mediated Respiratory sensitization in workers exposed to hexahydrophthalic anhydride.
- Asthma and rhinitis due to ethylcyanoacrylate instant glue.
- Clinical and immunologic studies among egg-processing workers with occupational Asthma.
- Pulmonary and immunologic evaluation of foundry workers exposed to methylene diphenyldiisocyanate (MDI).
- Spontaneous expression of the interleukin 2 receptor gene and presence of functional interleukin 2 receptors on T lymphocytes in the blood of individuals with active p...
- Chronic Asthma due to toluene diisocyanate.
- Persistent airways Disease caused by toluene diisocyanate.
- Delayed anaphylactoid reaction in a worker exposed to chromium.
- Cells and cytokines involved in the pathogenesis of Sarcoidosis.
- T-cell receptor genes in Sarcoidosis.
- Involvement of T cells and alterations in T cell receptors in Sarcoidosis.
- Bias toward use of a specific T cell receptor beta-chain variable region in a subgroup of individuals with Sarcoidosis.
- Increased numbers of T lymphocytes with gamma delta-positive antigen receptors in a subgroup of individuals with Pulmonary sarcoidosis.
- Preferential usage of the T-cell antigen receptor beta-chain constant region C beta 1 element by lung T-lymphocytes of patients with Pulmonary sarcoidosis.
- Familial aggregation of Sarcoidosis. A case-control etiologic study of Sarcoidosis (ACCESS).
- Clinical characteristics of patients in a case control study of Sarcoidosis.
- Attenuation of lung inflammation and Fibrosis in interferon-gamma-deficient mice after intratracheal bleomycin.
- Depression in Sarcoidosis.
- Genome-wide search for Sarcoidosis susceptibility genes in African Americans.
- Treatment of Sarcoidosis -- from a basic science point of view.
Schools
Tufts University
Albany Memorial Hospital
University Cincinnati
National Heart Lung Blood Institute
Procedures Preformed
- Bronchoscopy
- Ventilation Management
Conditions Treated
- Acidosis
- Angioedema
- Asthma
- Bronchiectasis
- View All
Doctors Specialties
- Pulmonology
Accepted Insurances
- Amerigroup (Wellpoint)
- Blue Card PPO
- Blue Preferred PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- CoreSource
- Coventry Health Care
- Geisinger Health Plan
- Choice Care PPO
- Kaiser Permanente
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Tricare
- Choice Plus POS
- Navigate HMO
- Options PPO
- United Healthcare
- Wells Fargo Insurance
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University Hospital - University of Cincinnati College of Medicine -
Albany Medical Center -
Tufts University School of Medicine
Hospital
-
Johns Hopkins Hospital -
Johns Hopkins Bayview Medical Center
Drug Facts
| NPI NUMBER | 1205887536 | |
| NPPES Provider LastName | MOLLER | |
| NPPES Provider FirstName | DAVID | |
| NPPES Provider ZIPCode | 212870005 | |
| NPPES Provider State | MD | |
| Specialty Description | Pulmonary Disease | |
| Total Claim Count | 176.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1205887536 |
| Last Name Of The Provider | MOLLER |
| First Name Of The Provider | DAVID |
| View All |
Similar Doctors
|
|
Dr. Majid Shafiq, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward I. Obazee, MD |
|
|
Dr. Paul Hassoun, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey D. Hasday, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Janaki Deepak, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bruce Marshall, MD |
|
|
Dr. Emmanuelle M. Clerisme-Beaty, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maximilian Mulder, MD
This Doctor is OpenDoctor Recommended.
|